Heron Therapeutics, Inc. / Insider Transactions

    Source Name Title Transaction Date Shares Price Value

    Configure table

    Control which columns are visible

    Export the current table view as a CSV file, which you can open in programs like Excel or Google Sheets.
    SEC Morgan Adam N/A +1.8M $1.50 +$2.65M
    SEC Forbes William P EVP, Chief Development Officer +25K $1.09 +$27.25K
    SEC Collard Craig A Chief Executive Officer +150K $0.92 +$138.00K
    SEC Duarte Ira EVP, Chief Financial Officer +85K $0.89 +$75.65K
    SEC Forbes William P EVP, Chief Development Officer +50K $0.94 +$47.00K
    SEC Morgan Adam N/A +2.5M $1.37 +$3.41M
    SEC MANHARD KIMBERLY EVP, Drug Development +5.5K $3.22 +$17.57K
    SEC Peraza Lisa VP, Chief Accounting Officer +1.5K $3.17 +$4.67K
    SEC POYHONEN JOHN President & CCO +3.8K $3.17 +$12.05K
    SEC Quart Barry D Chief Executive Officer +16K $3.19 +$51.69K
    SEC Szekeres David Leslie EVP, Chief Operating Officer +5.5K $3.22 +$17.57K
    SEC MANHARD KIMBERLY EVP, Drug Development +3.8K $3.76 +$14.30K
    SEC Peraza Lisa VP, Chief Accounting Officer +1.6K $3.76 +$6.11K
    SEC POYHONEN JOHN President & CCO +3.8K $3.76 +$14.30K
    SEC Quart Barry D Chief Executive Officer +15K $3.76 +$54.70K
    SEC Szekeres David Leslie EVP, Chief Operating Officer +3.8K $3.76 +$14.30K
    SEC MANHARD KIMBERLY EVP, Drug Development +3.8K $8.30 +$31.56K
    SEC Peraza Lisa VP, Chief Accounting Officer +1.5K $8.30 +$12.61K
    SEC POYHONEN JOHN President & CCO +3.8K $8.30 +$31.56K
    SEC Quart Barry D Chief Executive Officer +15K $8.30 +$120.76K
    SEC Szekeres David Leslie EVP, Chief Operating Officer +3.8K $8.30 +$31.56K
    SEC Christian Waage N/A -300 $9.73 -$2.92K
    SEC Johnson Craig A N/A -250 $9.73 -$2.43K
    SEC Christian Waage N/A -300 $12.31 -$3.69K
    SEC Johnson Craig A N/A -250 $12.30 -$3.08K
    SEC Christian Waage N/A -300 $15.20 -$4.56K
    SEC Johnson Craig A N/A -250 $15.20 -$3.80K
    SEC Christian Waage N/A -300 $17.51 -$5.25K
    SEC Johnson Craig A N/A -250 $17.22 -$4.31K
    SEC MANHARD KIMBERLY EVP, Drug Development +817 $18.16 +$14.84K
    SEC Peraza Lisa VP, Chief Accounting Officer +325 $18.16 +$5.90K
    SEC POYHONEN JOHN President & CCO +817 $18.16 +$14.84K
    SEC Quart Barry D Chief Executive Officer +2.7K $18.16 +$48.72K
    SEC Szekeres David Leslie EVP, Chief Operating Officer -3.6K $19.66 -$70.21K
    SEC POYHONEN JOHN President & CCO +637 $11.65 +$7.42K
    SEC TANG KEVIN C N/A +286K $17.50 +$5.00M
    SEC POYHONEN JOHN EVP, Chief Commercial Officer +5.1K $17.50 +$90.00K
    SEC Quart Barry D Chief Executive Officer +5.4K $17.64 +$94.85K
    SEC POYHONEN JOHN N/A +3K $17.55 +$52.65K
    SEC Christian Waage N/A +1.4K $18.04 +$25.26K
    SEC Quart Barry D Chief Executive Officer +20K $7.20 +$141.66K
    SEC TANG CAPITAL PARTNERS LP N/A -2.7M $35.75 -$96.35M
    SEC HOFFMAN ROBERT CFO & SVP, Finance +744 $26.57 +$19.77K
    SEC Quart Barry D Chief Executive Officer +1.6K $23.88 +$38.38K
    SEC TANG CAPITAL PARTNERS LP N/A +192K $26.00 +$5.00M
    SEC POYHONEN JOHN N/A +10K $12.20 +$122.00K
    SEC TANG CAPITAL PARTNERS LP N/A +2.5M $12.20 +$30.00M
    SEC Rosen Robert President & CCO -100K $23.30 -$2.33M
    SEC Rosen Robert President -200K $23.23 -$4.65M
    SEC TANG CAPITAL PARTNERS LP N/A +121K $24.75 +$3.00M
    SEC MANHARD KIMBERLY N/A -13K $23.09 -$304.97K
    SEC TANG CAPITAL PARTNERS LP N/A +150K $20.62 +$3.09M
    SEC Marshall Paul SVP, Technical Operations -70K $14.69 -$1.03M
    SEC Quart Barry D Chief Executive Officer -10K $13.07 -$130.70K
    SEC Midler Andrew R N/A -16K $10.78 -$172.48K
    SEC Savitr Capital, LLC N/A -97K $12.85 -$1.25M
    SEC Quart Barry D Chief Executive Officer +10K $11.75 +$117.50K
    SEC TANG CAPITAL PARTNERS LP N/A +511K $11.75 +$6.00M

    Notifications